NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA

Author's Avatar
Nov 19, 2020
Article's Main Image

SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, announced today that Mr. Brian Zucker, CPA, has joined the Company's Board of Directors, effective November 13, 2020, as an independent director. He was also appointed as a member of the Board's Audit Committee, Nomination Committee and Compensation Committee.